These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Phase II study of alpha interferon on renal cell carcinoma. Summary of three collaborative trials. Umeda T; Niijima T Cancer; 1986 Sep; 58(6):1231-5. PubMed ID: 3742449 [TBL] [Abstract][Full Text] [Related]
4. Improvement of psoriasis and cutaneous side-effects during tyrosine kinase inhibitor therapy for renal metastatic adenocarcinoma. A role for epidermal growth factor receptor (EGFR) inhibitors in psoriasis? Wierzbicka E; Tourani JM; Guillet G Br J Dermatol; 2006 Jul; 155(1):213-4. PubMed ID: 16792781 [No Abstract] [Full Text] [Related]
6. [Treatment of metastatic renal cell carcinoma with human lymphoblastoid interferon]. Ryu S; Fukuoka M; Tamai S; Takifuji N; Sakai N; Matsui K; Negoro S; Takada M; Kusunoki Y Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):996-1002. PubMed ID: 3694004 [No Abstract] [Full Text] [Related]
7. A randomized study of low and high doses of leukocyte alpha-interferon in metastatic renal cell carcinoma: the American Cancer Society collaborative trial. Kirkwood JM; Harris JE; Vera R; Sandler S; Fischer DS; Khandekar J; Ernstoff MS; Gordon L; Lutes R; Bonomi P Cancer Res; 1985 Feb; 45(2):863-71. PubMed ID: 3881175 [TBL] [Abstract][Full Text] [Related]
8. Phase II results with recombinant interferons: renal cell carcinoma and malignant melanoma. Kuzmits R; Kokoschka EM; Micksche M; Ludwig H; Flener R Oncology; 1985; 42 Suppl 1():26-32. PubMed ID: 4080298 [TBL] [Abstract][Full Text] [Related]
9. Phase II study of interferon alpha in metastatic renal-cell carcinoma: a progress report. Quesada JR; Swanson DA; Gutterman JU J Clin Oncol; 1985 Aug; 3(8):1086-92. PubMed ID: 4020410 [TBL] [Abstract][Full Text] [Related]
10. Recombinant interferon alpha and gamma in combination as treatment for metastatic renal cell carcinoma. Quesada JR; Evans L; Saks SR; Gutterman JU J Biol Response Mod; 1988 Jun; 7(3):234-9. PubMed ID: 3134511 [TBL] [Abstract][Full Text] [Related]
11. A phase IA trial of sequential administration recombinant DNA-produced interferons: combination recombinant interferon gamma and recombinant interferon alfa in patients with metastatic renal cell carcinoma. Ernstoff MS; Nair S; Bahnson RR; Miketic LM; Banner B; Gooding W; Day R; Whiteside T; Hakala T; Kirkwood JM J Clin Oncol; 1990 Oct; 8(10):1637-49. PubMed ID: 2120392 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of metastatic renal adenocarcinomas with combined recombinant alpha-2a interferon and vinblastine]. Bergerat JP; Dufour P; Soyer Y; Bollack C; Jacqmin D; Prevot G; Juraschek F; Bailly G; de Garis S; Lang JM Presse Med; 1987 Nov; 16(39):1953-6. PubMed ID: 2962158 [TBL] [Abstract][Full Text] [Related]
13. The use of interferon alpha-C in patients with metastatic renal cell carcinoma arising in a congenital solitary kidney. Merimsky O; Merimsky E; Chaitchik S J Surg Oncol; 1990 Dec; 45(4):279-81. PubMed ID: 2250479 [TBL] [Abstract][Full Text] [Related]
14. [Biological effect of recombined leukocyte alpha-2-interferon in metastasizing colorectal cancers]. Niederle N; Kurschel E; Schmidt CG Dtsch Med Wochenschr; 1984 May; 109(20):779-82. PubMed ID: 6723531 [TBL] [Abstract][Full Text] [Related]
15. Treatment of renal cell carcinoma with daily low-dose alpha-interferon. Marshall ME; Simpson W; Butler K; Fried A; Fer M J Biol Response Mod; 1989 Oct; 8(5):453-61. PubMed ID: 2795090 [TBL] [Abstract][Full Text] [Related]